61
Views
38
CrossRef citations to date
0
Altmetric
Original Article

Multiple Patterns of MDM-2 Deregulation in Human Leukemias: Implications in Leukemogenesis and Prognosis

, , , , &
Pages 13-18 | Received 21 May 1994, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ismael J. Samudio, Seshagiri Duvvuri, Karen Clise-Dwyer, Julie C. Watt, Duncan Mak, Hagop Kantarjian, Dajun Yang, Vivian Ruvolo & Gautam Borthakur. (2010) Activation of p53 signaling by MI-63 induces apoptosis in acute myeloid leukemia cells. Leukemia & Lymphoma 51:5, pages 911-919.
Read now
Britt Gustafsson, Olle Stål & Bertil Gustafsson. (1998) Overexpression of MDM2 in Acute Childhood Lymphoblastic Leukemia. Pediatric Hematology and Oncology 15:6, pages 519-526.
Read now
Dale S. Haines. (1997) The mdm2 Proto-Oncogene. Leukemia & Lymphoma 26:3-4, pages 227-238.
Read now
Ute M. Moll, Anne G. Ostermeyer, Robert Haladay, Blonka Winkfield, Mark Frazier & Gerard Zambetti. (1996) Cytoplasmic Sequestration of Wild-Type p53 Protein Impairs the G1 Checkpoint after DNA Damage. Molecular and Cellular Biology 16:3, pages 1126-1137.
Read now

Articles from other publishers (34)

Sisir Nandi & Manish C. Bagchi. (2022) Exploring CDKs, Ras-ERK, and PI3K-Aktin Abnormal Signaling and Cancer. Journal of Cancer Research Updates 11, pages 63-69.
Crossref
Sisir Nandi, Rishita Dey, Sudatta Dey, Asmita Samadder & Anil Kumar Saxena. (2022) Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography. Anti-Cancer Agents in Medicinal Chemistry 22:3, pages 485-498.
Crossref
Andrea Rodríguez-Alonso, Alba Casas-Pais, Daniel Roca-Lema, Begoña Graña, Gabriela Romay & Angélica Figueroa. (2020) Regulation of Epithelial–Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer. Cancers 12:11, pages 3093.
Crossref
Vincenzo Carafa, Rosita Russo, Laura Della Torre, Francesca Cuomo, Carmela Dell'Aversana, Federica Sarno, Giulia Sgueglia, Marzia Di Donato, Dante Rotili, Antonello Mai, Angela Nebbioso, Gilda Cobellis, Angela Chambery & Lucia Altucci. (2020) The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line. Frontiers in Oncology 10.
Crossref
Rana Elkholi, Ioana Abraham-Enachescu, Andrew P. Trotta, Camila Rubio-Patiño, Jarvier N. Mohammed, Mark P.A. Luna-Vargas, Jesse D. Gelles, Joshua R. Kaminetsky, Madhavika N. Serasinghe, Cindy Zou, Sumaira Ali, Gavin P. McStay, Cathie M. Pfleger & Jerry Edward Chipuk. (2019) MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network. Molecular Cell 74:3, pages 452-465.e7.
Crossref
Julia Abramowitz, Tzahi Neuman, Riki Perlman & Dina Ben-Yehuda. (2017) Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia. BMC Medical Genomics 10:1.
Crossref
Ya-Huei Kuo, Jing Qi & Guerry J. Cook. (2016) Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition. Experimental Hematology 44:5, pages 315-321.
Crossref
Yu-Tien Chang. (2014) Verification of gene expression profiles for colorectal cancer using 12 internet public microarray datasets. World Journal of Gastroenterology 20:46, pages 17476.
Crossref
Yu-Tien Chang. (2014) Gene expression profile of peripheral blood in colorectal cancer. World Journal of Gastroenterology 20:39, pages 14463.
Crossref
H. Joachim Deeg, David T. Bowen, Steven D. Gore, Torsten Haferlach, Michelle M. Le Beau & Charlotte NiemeyerHarold J. Olney & Michelle M. Le Beau. 2013. Myelodysplastic Syndromes. Myelodysplastic Syndromes 41 72 .
Mustafa IsinMustafa YenerelMelih AktanNur BuyruNejat Dalay. (2012) Analysis of p53 Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia . DNA and Cell Biology 31:5, pages 777-782.
Crossref
LIN WANG, XIAO-YING ZHANG, LING XU, WEN-JUN LIU, JUAN ZHANG & JIAN-PING ZHANG. (2011) Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma. Oncology Letters 2:4, pages 707-712.
Crossref
Nancy S Magnuson, Zeping Wang, Gang Ding & Raymond Reeves. (2010) Why target PIM1 for cancer diagnosis and treatment?. Future Oncology 6:9, pages 1461-1478.
Crossref
. 2010. Cancer Cytogenetics. Cancer Cytogenetics 141 178 .
Ismael Samudio, Marina Konopleva, Bing Carter & Michael Andreeff. 2010. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 197 217 .
M Dimitriadi, G Poulogiannis, L Liu, L M Bäcklund, D M Pearson, K Ichimura & V P Collins. (2008) p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours. British Journal of Cancer 99:7, pages 1144-1152.
Crossref
Paola Secchiero, Carlotta Zerbinati, Elisabetta Melloni, Daniela Milani, Diana Campioni, Roberto Fadda, Mario Tiribelli & Giorgio Zauli. (2007) The MDM-2 Antagonist Nutlin-3 Promotes the Maturation of Acute Myeloid Leukemic Blasts. Neoplasia 9:10, pages 853-861.
Crossref
H. J. Deeg, D. T. Bowen, S. D. Gore, T. Haferlach, M. M. Le Beau & C. NiemeyerHarold J. Olney & Michelle M. Le Beau. 2006. Hematologic Malignancies: Myelodysplastic Syndromes. Hematologic Malignancies: Myelodysplastic Syndromes 55 79 .
Harold J. Olney & Michelle M. Le Beau. 2009. Myelodysplastic Syndromes. Myelodysplastic Syndromes 95 128 .
Ming Dong. (2005) Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer. World Journal of Gastroenterology 11:14, pages 2162.
Crossref
Stanley R. Riddell & Philip D. Greenberg. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation 380 404 .
Katrien Vermeulen, Dirk R. Van Bockstaele & Zwi N. Berneman. (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferation 36:3, pages 131-149.
Crossref
Michaela Herzig & Gerhard Christofori. (2002) Recent advances in cancer research: mouse models of tumorigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1602:2, pages 97-113.
Crossref
Andrew R. PettittPaul D. SherringtonGrant StewartJohn C. CawleyA. Malcolm R. TaylorTatjana Stankovic. (2001) p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative toTP53 mutation. Blood 98:3, pages 814-822.
Crossref
Stefan Faderl, Hagop M. Kantarjian, Elihu Estey, Taghi Manshouri, Ching-Yang Chan, Abdel Rahman Elsaied, Steven M. Kornblau, Jorge Cortes, Deborah A. Thomas, Sherry Pierce, Michael J. Keating, Zeev Estrov & Maher Albitar. (2000) The prognostic significance of p16 INK4a /p14 ARF locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia . Cancer 89:9, pages 1976-1982.
Crossref
James W. Jacobberger, R. Michael Sramkoski, Desheng Zhang, Louis A. Zumstein, Lesah D. Doerksen, James A. Merritt, Susan A. Wright & Keith E. Shults. (1999) Bivariate analysis of the p53 pathway to evaluate Ad-p53 gene therapy efficacy. Cytometry 38:5, pages 201-213.
Crossref
M Alkhalaf, G Ganguli, N Messaddeq, M Le Meur & B Wasylyk. (1999) MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice. Oncogene 18:7, pages 1419-1434.
Crossref
Zhe Yu, Jian Chen, Barry N. Ford, Moyra E. Brackley & Barry W. Glickman. (1999) Human DNA repair systems: An overview. Environmental and Molecular Mutagenesis 33:1, pages 3-20.
Crossref
Gerrard TeohMitsuyoshi UrashimaAtsushi OgataDharminder ChauhanJames A. DeCaprioSteven P. TreonRobert L. SchlossmanKenneth C. Anderson. (1997) MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells. Blood 90:5, pages 1982-1992.
Crossref
PB Sugerman & EJ Shillitoe. (2008) The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Diseases 3:3, pages 130-147.
Crossref
VASSILIS G. GORGOULIS, VASSILIS ZOUMPOURLIS, GEORGE Z. RASSIDAKIS, ANDREAS KARAMERIS, ANTONIS N. RASSIDAKIS, DEMETRIOS A. SPANDIDOS & CHRISTOS KITTAS. (1996) A MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF THE MDM2 PROTEIN ISOFORMS ANDp53 GENE PRODUCT IN BRONCHOGENIC CARCINOMA. The Journal of Pathology 180:2, pages 129-137.
Crossref
Barbara Seliger, Stefan Papadileris, Detlef Vogel, Georg Hess, Cornelia Brendel, Stephen Störkel, Joachim örtel, Karin Kolbe, Christoph Huber, Dieter Huhn & Andreas Neubauer. (2009) Analysis of the p53 and MDM‐2 gene in acute myeloid leukemia . European Journal of Haematology 57:3, pages 230-240.
Crossref
C D Fegan & F E Davies. (1996) Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia. Molecular Pathology 49:4, pages M185-M191.
Crossref
Carlos E. Bueso-Ramos, Taghi Manshouri, Mohammad A. Haidar, Yun Yang, Patrick McCown, Nelson Ordonez, Armand Glassman, Nour Sneige & Maher Albitar. (1996) Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Research and Treatment 37:2, pages 179-188.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.